Zacks Research Issues Negative Outlook for Revvity Earnings

Revvity, Inc. (NYSE:RVTY - Free Report) - Equities research analysts at Zacks Research lowered their Q3 2024 earnings per share (EPS) estimates for Revvity in a research note issued to investors on Tuesday, October 22nd. Zacks Research analyst R. Department now anticipates that the company will post earnings of $1.12 per share for the quarter, down from their prior forecast of $1.13. The consensus estimate for Revvity's current full-year earnings is $4.75 per share. Zacks Research also issued estimates for Revvity's Q2 2025 earnings at $1.27 EPS, Q3 2025 earnings at $1.29 EPS, FY2025 earnings at $5.15 EPS, Q2 2026 earnings at $1.39 EPS and FY2026 earnings at $5.65 EPS.

Several other brokerages also recently commented on RVTY. JPMorgan Chase & Co. upped their price target on shares of Revvity from $105.00 to $120.00 and gave the company a "neutral" rating in a research report on Tuesday, July 30th. Leerink Partners increased their target price on Revvity from $130.00 to $135.00 and gave the company an "outperform" rating in a report on Thursday, October 17th. TD Cowen raised their target price on Revvity from $130.00 to $141.00 and gave the stock a "buy" rating in a research report on Tuesday, July 30th. Citigroup upped their price target on Revvity from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Tuesday, July 30th. Finally, Wells Fargo & Company initiated coverage on Revvity in a research note on Tuesday, August 27th. They issued an "equal weight" rating and a $130.00 price objective for the company. Seven analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $127.20.

Revvity Trading Down 2.0 %

Shares of RVTY traded down $2.34 during midday trading on Thursday, hitting $116.16. The stock had a trading volume of 730,411 shares, compared to its average volume of 815,659. The business has a 50-day simple moving average of $121.58 and a two-hundred day simple moving average of $113.43. The firm has a market cap of $14.33 billion, a P/E ratio of 96.00, a price-to-earnings-growth ratio of 3.35 and a beta of 1.05. The company has a current ratio of 2.27, a quick ratio of 1.98 and a debt-to-equity ratio of 0.40. Revvity has a fifty-two week low of $79.50 and a fifty-two week high of $128.15.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, July 29th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.12 by $0.10. The business had revenue of $691.70 million during the quarter, compared to the consensus estimate of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. Revvity's revenue was down 2.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.21 earnings per share.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 7th. Stockholders of record on Friday, January 17th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.24%. Revvity's dividend payout ratio is 23.14%.

Insider Activity at Revvity

In other news, insider Tajinder S. Vohra sold 2,154 shares of Revvity stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $121.73, for a total transaction of $262,206.42. Following the sale, the insider now owns 19,652 shares of the company's stock, valued at approximately $2,392,237.96. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Revvity news, insider Tajinder S. Vohra sold 2,153 shares of the firm's stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $122.09, for a total transaction of $262,859.77. Following the completion of the transaction, the insider now owns 23,960 shares in the company, valued at $2,925,276.40. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Tajinder S. Vohra sold 2,154 shares of Revvity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $121.73, for a total value of $262,206.42. Following the sale, the insider now directly owns 19,652 shares in the company, valued at $2,392,237.96. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,807 shares of company stock worth $937,576. Company insiders own 0.60% of the company's stock.

Institutional Trading of Revvity

Several institutional investors have recently bought and sold shares of RVTY. EdgePoint Investment Group Inc. bought a new position in shares of Revvity during the second quarter valued at $209,221,000. Jane Street Group LLC lifted its holdings in Revvity by 516.4% during the 1st quarter. Jane Street Group LLC now owns 453,343 shares of the company's stock valued at $47,601,000 after purchasing an additional 379,802 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Revvity by 18.5% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,126,271 shares of the company's stock valued at $223,258,000 after buying an additional 332,632 shares in the last quarter. Janus Henderson Group PLC boosted its position in Revvity by 3.9% in the first quarter. Janus Henderson Group PLC now owns 5,664,528 shares of the company's stock valued at $594,769,000 after buying an additional 210,100 shares in the last quarter. Finally, Coronation Fund Managers Ltd. grew its stake in Revvity by 261.3% during the first quarter. Coronation Fund Managers Ltd. now owns 253,722 shares of the company's stock worth $26,641,000 after buying an additional 183,490 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.